Literature DB >> 7270948

Effects of high-dose fentanyl anesthesia on the electroencephalogram.

P S Sebel, J G Bovill, A Wauquier, P Rog.   

Abstract

The purpose of this study was to define the EEG changes produced in humans by fentanyl 30-70 microgram/kg during cardiac surgery. The authors have also assessed awareness in the patients. Thirty-nine patients were studied; oral lorazepam or intramuscular morphine was used as premedication. Anesthesia was induced with intravenous injection of fentanyl over 2 min and the patients were ventilated with either air/O2 (24 patients) or N2O/O2 (15 patients). The EEGs recorded until the start of cardiopulmonary bypass were visually analyzed, classified into EEG stage, and plotted graphically as narcograms. Computerized 3-dimensional power spectral analysis and wide band spectral analysis were carried out on representative EEGs. The EEG effects of fentanyl are consistent and are characterized by high-voltage slow delta waves. Nitrous oxide had no effect on the EEG responses to fentanyl. Computer analysis confirmed the visual interpretation. There was no incidence of awareness. The authors conclude from this study that fentanyl after premedication is a suitable drug for providing unconsciousness, analgesia, and amnesia during cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270948     DOI: 10.1097/00000542-198109000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  21 in total

Review 1.  Perioperative stroke. Part I: General surgery, carotid artery disease, and carotid endarterectomy.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

2.  Guidelines for intraoperative neuromonitoring using raw (analog or digital waveforms) and quantitative electroencephalography: a position statement by the American Society of Neurophysiological Monitoring.

Authors:  Michael R Isley; Harvey L Edmonds; Mark Stecker
Journal:  J Clin Monit Comput       Date:  2009-09-16       Impact factor: 2.502

Review 3.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

4.  Prognostic value of early somatosensory evoked potentials during carotid surgery: relationship with electroencephalogram, stump pressure and clinical outcome.

Authors:  G Pozzessere; E Valle; A Santoro; R Delfini; P A Rizzo; G P Cantore; C Morocutti
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 5.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

6.  Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine.

Authors:  C J Watson; R Lydic; H A Baghdoyan
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

Review 7.  Perioperative stroke. Part II: Cardiac surgery and cardiogenic embolic stroke.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

8.  Calabadion 1 selectively reverses respiratory and central nervous system effects of fentanyl in a rat model.

Authors:  Tharusan Thevathasan; Stephanie D Grabitz; Peter Santer; Paul Rostin; Oluwaseun Akeju; James D Boghosian; Monica Gill; Lyle Isaacs; Joseph F Cotten; Matthias Eikermann
Journal:  Br J Anaesth       Date:  2020-03-30       Impact factor: 9.166

9.  Opioid-induced decreases in rat brain adenosine levels are reversed by inhibiting adenosine deaminase.

Authors:  Ariana M Nelson; Alanna S Battersby; Helen A Baghdoyan; Ralph Lydic
Journal:  Anesthesiology       Date:  2009-12       Impact factor: 7.892

Review 10.  Sleep in the intensive care unit.

Authors:  Sairam Parthasarathy; Martin J Tobin
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.